Schellenberg Wittmer has advised Swiss Start-up Swiss4.0 in obtaining its Fintech license with the Swiss Financial Market Supervisory Authority (FINMA). Swiss4 is a state-of-the-art banking services application that brings the experience of private banking to the digital space. Through an exclusive community, clients can discover a new generation of Swiss financial services. The company is […]
Niederer Kraft Frey has advised Bank of America, acting as bookrunning mandated lead arranger, on the financing of DKSH’s acquisition of Terra Firma, a leading distributor of specialty chemicals in North America, and the
Advestra has advised InfraVia III Green and its Swiss subsidiaries Green Group, Green Datacenter and green.ch in connection with their compre
The Mobility House (TMH), a technology company and solution provider for charging services, has recently secured an equity investment of around EUR 50 million from its existing investors. The internal round of financing to support company’
Kellerhals Carrard advised BKW as borrower of its CHF 1.5 billion syndicated multicurrency revolving credit facility. BKW is an international energy and infrastructure company and offers integrated solutions in the fields of energy, buildings and infrastructure.
Walder Wyss has advised Farmy, a leading Swiss e-commerce startup, on a crowdfunding campaign in the amount of CHF 4.3 million. As part of the financing round, convertible loans in the amount of CHF 2 million from
As we have informed last 15 November 2022 here, Hangzhou GreatStar Industrial, whose A Shares are listed on the Shenzhen Stock Exchange, became the eighth Chinese company that has listed global depositary receipts (GDRs) on the SIX
Homburger has acted as counsel to UBS Switzerland as mandated lead arranger, agent, security agent and original lender in connection with the financing of the acquisition of Studer Cables’s parent company HC Holding Epsilon
Homburger has advised Credit Suisse and UBS Switzerland in connection with the financing of Farner Consulting in support of its international buy-&-build strategy. Farner Consulting, together with its subsidiaries Rod and DU DA,
Anokion, a clinical-stage biotechnology company focused on treating autoimmune disease by restoring normal immune tolerance, recently closed an USD 35 million equity investment from Pfizer through the Pfizer Breakthrough Growth Initiative. Founded in Switzerland and based
